CUE Cue Biopharma, Inc.
Fundamentals / CIK 0001645460 / USDCue Biopharma, Inc. reported $35.64M in revenue and a net loss of $206.7M for the trailing twelve months ended September 30, 2026 (down 93.9% year over year), with a -387.7% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CUE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$35.64M -93.9% YoY
-
Operating Income TTM-$138.2M -387.7% margin
-
Net Income TTM-$206.7M -579.9% net margin
-
Diluted EPS TTM-$19.57 Split-adjusted
-
Free Cash Flow TTM-$51.23M -143.7% FCF margin
-
Cash & ST Investments Sep 30, 2026$57.94M Total debt: --
Annual revenue and net income
9 fiscal years (2017 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.47M | $9.29M | $5.49M | $1.25M | $14.94M | $3.15M | $3.46M | $1.14M | -- |
| Research & Development | $37.74M | $36.30M | $40.80M | $38.58M | $41.35M | $33.55M | $27.49M | $28.54M | $18.90M |
| Total Operating Expenses | $54.02M | $50.79M | $57.64M | $54.47M | $58.65M | $48.20M | $40.23M | $39.84M | $23.23M |
| Operating Income | -$26.55M | -$41.50M | -$52.15M | -$53.23M | -$43.71M | -$45.04M | -$36.77M | -$38.70M | -$23.23M |
| EBITDA | -$25.59M | -$41.10M | -$51.59M | -$52.30M | -$42.45M | -$43.99M | -$35.96M | -$37.94M | -$22.81M |
| Interest Expense | $100K | $100K | $100K | $109K | -- | -- | -- | -- | -- |
| Income Before Tax | -- | -- | -- | -$53.01M | -$43.67M | -$44.58M | -$36.29M | -$38.16M | -$23.23M |
| Income Tax Expense | $500K | $0 | -- | $0 | $495K | $206K | $412K | $825K | -- |
| Net Income | -$26.60M | -$40.67M | -$50.73M | -$53.01M | -$44.16M | -$44.78M | -$36.70M | -$38.98M | -$23.23M |
| Basic EPS | -$8.41 | -$21.62 | -$33.33 | -$44.74 | -$42.34 | -$46.85 | -$49.85 | -$58.26 | -$64.86 |
| Diluted EPS | -$8.41 | -$21.62 | -$33.33 | -$44.74 | -$42.34 | -$46.85 | -$49.85 | -$58.26 | -$64.86 |
| Basic Shares Outstanding | 3.2M | 1.9M | 1.5M | 1.2M | 1.0M | 955.3K | 734.0K | 670.5K | 357.4K |
| Diluted Shares Outstanding | 3.2M | 1.9M | 1.5M | 1.2M | 1.0M | 955.3K | 734.0K | 670.5K | 357.4K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $132K | $7.88M | $5.69M | $21.94M | $2.15M | $2.95M | $421K | $1.58M |
| Research & Development | $17.02M | $49.01M | $6.90M | $16.53M | $4.75M | $7.91M | $8.55M | $7.18M |
| Total Operating Expenses | $47.23M | $95.57M | $11.04M | $19.96M | $9.74M | $11.59M | $12.72M | $11.21M |
| Operating Income | -$47.10M | -$87.69M | -$5.35M | $1.98M | -$7.59M | -$8.63M | -$12.30M | -$9.63M |
| EBITDA | -$47.06M | -$87.66M | -$4.79M | $2.66M | -$7.51M | -$8.54M | -$12.20M | -$9.54M |
| Interest Expense | -- | -- | -- | $2.0K | $33K | $33K | $100K | -- |
| Net Income | -$50.02M | -$153.1M | -$5.18M | $1.58M | -$7.45M | -$8.48M | -$12.26M | -$9.50M |
| Basic EPS | -$4.74 | -$24.14 | -$1.08 | -- | -$2.22 | -$2.67 | -$4.95 | -- |
| Diluted EPS | -$4.74 | -$24.14 | -$1.08 | -- | -$2.22 | -$2.67 | -$4.95 | -- |
| Basic Shares Outstanding | 10.6M | 6.3M | 4.8M | -- | 3.4M | 3.2M | 2.5M | -- |
| Diluted Shares Outstanding | 10.6M | 6.3M | 4.8M | -- | 3.4M | 3.2M | 2.5M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $27.14M | $22.46M | $48.51M | $51.61M | $64.37M | $74.87M | $44.29M | $20.80M | $63.53M |
| Short-Term Investments | -- | $0 | $0 | $24.68M | $0 | $10.00M | $15.12M | $18.41M | $0 |
| Cash & Short-Term Investments | $27.14M | $22.46M | $48.51M | $76.29M | $64.40M | $84.90M | $59.41M | $39.21M | $63.53M |
| Accounts Receivable, Net | $5.55M | $945K | $1.70M | $57K | $3.14M | $1.42M | $755K | -- | -- |
| Total Current Assets | $36.98M | $25.14M | $51.45M | $77.19M | $68.47M | $87.53M | $61.02M | $40.61M | $65.07M |
| Property, Plant & Equipment, Net | $241K | $471K | $795K | $1.50M | $2.11M | $2.11M | $1.85M | $2.78M | $1.69M |
| Other Non-Current Assets | $94K | $105K | $117K | $128K | $140K | $402K | $674K | $809K | $198K |
| Total Non-Current Assets | $5.23M | $7.05M | $10.08M | $14.10M | $14.93M | $12.01M | $10.58M | $4.75M | $1.89M |
| Total Assets | $42.21M | $32.19M | $61.53M | $91.28M | $83.40M | $99.53M | $71.61M | $45.36M | $66.95M |
| Accounts Payable | $3.95M | $2.82M | $3.50M | $2.73M | $2.59M | $2.07M | $883K | $2.04M | $1.66M |
| Short-Term Debt | -- | $37K | $4.04M | $2.07M | -- | -- | -- | -- | -- |
| Total Current Liabilities | $13.49M | $13.69M | $17.08M | $11.55M | $12.79M | $16.32M | $11.66M | $6.22M | $5.35M |
| Long-Term Debt | -- | $0 | $4.20M | $8.04M | $0 | -- | -- | -- | -- |
| Total Non-Current Liabilities | $2.29M | $1.00M | $7.36M | $14.05M | $5.12M | $4.31M | $5.37M | $5.17M | $0 |
| Total Liabilities | $15.78M | $14.69M | $24.45M | $25.60M | $17.91M | $20.62M | $17.02M | $11.39M | $5.35M |
| Total Debt (incl. Leases) | $4.20M | $4.58M | $8.25M | $19.43M | $10.05M | $7.15M | $5.80M | -- | -- |
| Common Stock | $3.0K | $62K | $47K | $43K | $32K | $30K | $27K | $21K | $19K |
| Retained Earnings | -$368.5M | -$341.9M | -$301.2M | -$250.5M | -$197.4M | -$153.3M | -$108.5M | -$71.80M | -$32.82M |
| Accumulated Other Comp. Income | -- | $0 | $0 | -$96K | $0 | $7.1K | -$10K | -$11K | -- |
| Total Stockholders' Equity | $26.43M | $17.50M | $37.09M | $65.68M | $65.49M | $78.91M | $54.58M | $33.97M | $61.61M |
| Total Equity | $26.43M | $17.50M | $37.09M | $65.68M | $65.49M | $78.91M | $54.58M | $33.97M | $61.61M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $57.94M | $17.39M | $16.38M | $27.14M | $11.70M | $27.49M | $13.14M | $22.46M |
| Short-Term Investments | -- | -- | -- | -- | $6.97M | -- | -- | $0 |
| Cash & Short-Term Investments | $57.94M | $17.39M | $16.38M | $27.14M | $18.67M | $27.49M | $13.14M | $22.46M |
| Accounts Receivable, Net | $5.13M | $5.38M | $5.35M | $5.55M | $387K | $532K | $0 | $945K |
| Total Current Assets | $66.71M | $26.62M | $26.39M | $36.98M | $25.82M | $30.84M | $15.93M | $25.14M |
| Property, Plant & Equipment, Net | $225K | $255K | $288K | $241K | $307K | $454K | $523K | $471K |
| Other Non-Current Assets | $85K | $88K | $90K | $94K | $96K | $283K | $102K | $105K |
| Total Non-Current Assets | $548K | $4.08M | $4.49M | $5.23M | $5.83M | $9.86M | $6.32M | $7.05M |
| Total Assets | $67.25M | $30.71M | $30.88M | $42.21M | $31.64M | $40.71M | $22.25M | $32.19M |
| Accounts Payable | $3.61M | $3.75M | $3.33M | $3.95M | $2.35M | $3.63M | $3.78M | $2.82M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | $100K | $37K |
| Total Current Liabilities | $19.73M | $21.22M | $7.39M | $13.49M | $15.52M | $19.25M | $15.50M | $13.69M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Non-Current Liabilities | $9.13M | $7.18M | $1.88M | $2.29M | $2.87M | $3.29M | $176K | $1.00M |
| Total Liabilities | $28.86M | $28.40M | $9.27M | $15.78M | $18.40M | $22.55M | $15.67M | $14.69M |
| Total Debt (incl. Leases) | -- | $3.08M | $3.44M | $4.20M | $4.71M | $5.22M | $3.85M | $4.58M |
| Common Stock | $8.0K | $5.0K | $3.0K | $3.0K | $78K | $76K | $62K | $62K |
| Retained Earnings | -$576.7M | -$526.7M | -$373.6M | -$368.5M | -$370.1M | -$362.6M | -$354.1M | -$341.9M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $1.0K | -- | -- | $0 |
| Total Stockholders' Equity | $38.40M | $2.31M | $21.61M | $26.43M | $13.25M | $18.16M | $6.58M | $17.50M |
| Total Equity | $38.40M | $2.31M | $21.61M | $26.43M | $13.25M | $18.16M | $6.58M | $17.50M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$26.60M | -$40.67M | -$50.73M | -$53.01M | -$44.16M | -$44.78M | -$36.70M | -$38.98M | -$23.23M |
| Depreciation & Amortization | $958K | $397K | $556K | $922K | $1.26M | $1.06M | $811K | $760K | $420K |
| Stock-Based Compensation | $4.74M | $6.85M | $8.18M | $9.50M | $11.52M | $10.48M | $6.52M | $7.17M | $2.78M |
| Change in Receivables | -$4.60M | $753K | -$1.64M | $3.08M | -$1.73M | -$663K | -$755K | -- | -- |
| Change in Payables | $1.12M | -$678K | $770K | $83K | $520K | $741K | -$1.15M | $376K | $922K |
| Operating Cash Flow | -$21.69M | -$36.33M | -$39.96M | -$41.81M | -$38.84M | -$32.49M | -$30.80M | -$26.41M | -$12.14M |
| Capital Expenditure | -$177K | -$66K | $0 | -$171K | -$913K | -$595K | -$46K | -$1.85M | -$1.03M |
| Free Cash Flow | -$21.86M | -$36.40M | -$39.96M | -$41.98M | -$39.75M | -$33.09M | -$30.84M | -$28.27M | -$13.17M |
| Purchases of Investments | -$16.29M | $0 | -- | -- | $0 | -$9.95M | -$15.13M | -- | -- |
| Investing Cash Flow | $75K | $32K | $25.00M | -$24.61M | $9.11M | $4.46M | $3.45M | -$20.35M | -$1.20M |
| Common Stock Issued | $28.29M | $10.81M | $0 | $22.70M | $0 | $56.68M | $49.00M | -- | -- |
| Share Repurchases | -- | -- | $0 | -$200K | -$750K | -$271K | -$91K | -- | -- |
| Financing Cash Flow | $26.29M | $10.24M | $11.86M | $53.66M | $19.23M | $58.61M | $50.79M | $4.18M | $62.00M |
| Net Change in Cash | $4.68M | -$26.05M | -$3.10M | -$12.76M | -$10.50M | $30.58M | $23.44M | -$42.58M | $48.66M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$50.02M | -$153.1M | -$5.18M | $1.58M | -$7.45M | -$8.48M | -$12.26M | -$9.50M |
| Depreciation & Amortization | $33K | $36K | $566K | $678K | $80K | $99K | $101K | $98K |
| Stock-Based Compensation | $35.48M | $23.84M | $48K | $610K | $1.53M | $1.26M | $1.34M | $1.56M |
| Change in Receivables | $245K | -$26K | $195K | -$5.16M | $145K | -$532K | $945K | $2.21M |
| Change in Payables | -$139K | $421K | -$622K | $1.60M | -$1.28M | -$157K | $961K | -$3.65M |
| Operating Cash Flow | -$10.08M | -$29.00M | -$10.94M | -$1.08M | -$9.02M | -$3.42M | -$8.17M | -$9.03M |
| Capital Expenditure | $0 | $0 | -$121K | $0 | $0 | -$27K | -$150K | -$2.0K |
| Free Cash Flow | -$10.08M | -$29.00M | -$11.06M | -$1.08M | -$9.02M | -$3.44M | -$8.32M | -$9.03M |
| Investing Cash Flow | $0 | $0 | -$121K | $7.02M | -$6.77M | -$27K | -$150K | -$1.0K |
| Financing Cash Flow | $50.63M | $30.02M | $306K | $9.49M | $1.0K | $17.80M | -$1.00M | -$932K |
| Net Change in Cash | $40.55M | $1.01M | -$10.76M | $15.44M | -$15.79M | $14.36M | -$9.32M | -$9.96M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -96.7% | -446.9% | -949.9% | -4275.1% | -292.6% | -1428.0% | -1063.2% | -3386.7% | -- |
| Net Profit Margin | -96.9% | -438.0% | -924.1% | -4257.8% | -295.6% | -1419.8% | -1061.2% | -3411.5% | -- |
| Return on Equity (ROE) | -100.6% | -232.4% | -136.8% | -80.7% | -67.4% | -56.8% | -67.2% | -114.7% | -37.7% |
| Return on Assets (ROA) | -63.0% | -126.4% | -82.5% | -58.1% | -53.0% | -45.0% | -51.3% | -85.9% | -34.7% |
| Current Ratio | 2.74x | 1.84x | 3.01x | 6.68x | 5.35x | 5.36x | 5.24x | 6.53x | 12.17x |
| Quick Ratio | 2.42x | 1.71x | 2.94x | 6.61x | 5.28x | 5.29x | 5.16x | 6.31x | 11.88x |
| Debt to Equity | 0.16x | 0.26x | 0.22x | 0.30x | 0.15x | 0.09x | 0.11x | -- | -- |
| Revenue Growth (YoY) | +195.7% | +69.2% | +341.0% | -91.7% | +373.7% | -8.8% | +202.7% | -- | -- |
| 5Y Revenue / Share Growth | +163.7% | +5.1% | +111.4% | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -387.7% | -262.0% | -59.9% | -96.7% | -537.5% | -475.2% | -514.7% | -446.9% |
| Net Profit Margin | -579.9% | -435.8% | -59.6% | -96.9% | -530.7% | -469.3% | -507.9% | -438.0% |
| Return on Equity (ROE) | -538.2% | -7104.2% | -90.4% | -100.6% | -284.5% | -214.2% | -616.8% | -232.4% |
| Return on Assets (ROA) | -307.3% | -534.4% | -63.2% | -63.0% | -119.1% | -95.5% | -182.4% | -126.4% |
| Current Ratio | 3.38x | 1.25x | 3.57x | 2.74x | 1.66x | 1.60x | 1.03x | 1.84x |
| Quick Ratio | 3.20x | 1.07x | 2.94x | 2.42x | 1.23x | 1.46x | 0.85x | 1.71x |
| Debt to Equity | -- | 1.33x | 0.16x | 0.16x | 0.36x | 0.29x | 0.59x | 0.26x |
| Revenue Growth (YoY) | -93.9% | +166.7% | +1250.6% | +1292.3% | -35.6% | +11.1% | -75.5% | -13.5% |